Lester Crawford



Lester Mills Crawford (born March 13, 1938) is a former Commissioner of the United States Food and Drug Administration (FDA). Dr. Crawford resigned from the FDA in September, 2005 - just two months after his approval by the Senate. On October 17, 2006, he pleaded guilty "to conflict of interest and false reporting of information about stocks he owned in food, beverage and medical device companies he was in charge of regulating."

Education
Crawford received a Doctor of Veterinary Medicine (DVM) degree from Auburn University in 1963 and a PhD in pharmacology from the University of Georgia in 1969.

Personal
Crawford has been married since 1963 to Catherine Walker of Birmingham, Alabama. They have two daughters, Leigh and Mary, and four grandchildren.

Career
Prior to becoming FDA Commissioner, Crawford had served as Deputy Commissioner of FDA since February 25, 2002. From 1997-2002, he was Director of the Center for Food and Nutrition Policy at Georgetown University and at Virginia Tech, where it moved to in 2001.

Crawford also served as Administrator of the Food Safety and Inspection Service (United States Department of Agriculture) from 1987 to 1991 as well as director of the FDA's Center for Veterinary Medicine from 1978 to 1980, and again from 1982 to 1985. Previously in his career he was chair of the Department of Physiology-Pharmacology at the University of Georgia, executive director of the Association of American Veterinary Medical Colleges, and a practicing veterinarian.

Nomination
On February 15, 2005, Crawford was nominated by President George W. Bush to head the FDA, pending U.S. Senate confirmation.

His nomination stalled for two months after he was accused of an extramarital affair with an FDA employee. An investigation by the Department of Health and Human Services inspector general found no evidence of an affair. On April 28, 2006 it was announced that he was being investigated by a Grand Jury over accusations of financial improprieties and false statements to Congress.

Senate approval
The Senate Health Committee approved the nomination on June 15, and Crawford was approved by the Senate on July 18.

Short-lived, Controversial FDA Career
Crawford resigned, effective immediately, on September 23 in a surprise announcement. The FDA had been under criticism since before his nomination to the post. His appointment was embattled from the beginning as several senators had threatened to place holds on his confirmation vote until the FDA made a decision on whether or not to allow over-the-counter sales of the "Plan B" or "Morning-after" emergency contraception pills.

The White House nominated Andrew von Eschenbach to succeed Crawford as commissioner.

Justice Deparment charges
On October 16, 2006, the US Justice Department formally charged Crawford with lying and violating conflict-of-interest laws for falsely reporting his ownership of stock in companies regulated by the FDA. . Specifically, according to the charging documents, he falsely stated in a 2004 government filing that shares of Sysco Corp. and Kimberly-Clark Corp. had been sold when he and his wife continued to hold them, and also failed to disclose income from exercising stock options in Embrex Inc. He pleaded guilty the next day.

On February 27, 2007, was sentenced to three years' supervised probation and fines of roughly $90,000.

Later lobbying career
Crawford followed his position at the FDA by joining a Washington lobbying firm, Policy Directions Inc.